0000899243-19-008569.txt : 20190320
0000899243-19-008569.hdr.sgml : 20190320
20190320171319
ACCESSION NUMBER: 0000899243-19-008569
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190319
FILED AS OF DATE: 20190320
DATE AS OF CHANGE: 20190320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayden Michael R
CENTRAL INDEX KEY: 0001352908
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36687
FILM NUMBER: 19695258
MAIL ADDRESS:
STREET 1: C/O ASPREVA PHARMACEUTICALS CORPORATION
STREET 2: 1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: V8Z 7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xenon Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001582313
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 980661854
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
BUSINESS PHONE: (604) 484-3300
MAIL ADDRESS:
STREET 1: 200 - 3650 GILMORE WAY
CITY: BURNABY
STATE: A1
ZIP: V5G 48W
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-03-19
0
0001582313
Xenon Pharmaceuticals Inc.
XENE
0001352908
Hayden Michael R
C/O XENON PHARMACEUTICALS INC
200 - 3650 GILMORE WAY
BURNABY
A1
V5G 4W8
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Shares
2019-03-19
4
M
0
20576
3.38
A
50924
I
By Genworks Inc.
Common Shares
114403
I
By wife
Common Shares
107562
D
Stock Option (Right to Buy)
3.38
2019-03-19
4
M
0
20576
0.00
D
2019-08-31
Common Shares
20576
0
I
By Genworks Inc.
The exercise price was converted from $3.74 CAD using the closing rate of exchange of the Bank of Canada on the date of grant. The actual exercise price is the Canadian dollar amount regardless of the exchange rate on the date of exercise.
The shares subject to the option fully vested on September 1, 2013.
Michael Hayden is the president and principal beneficial shareholder of Genworks Inc.
/s/ Barbara Mery, Attorney-in-fact
2019-03-20